CARE Canada Statement: Canada drawing on COVAX supply of COVID-19 vaccines
OTTAWA, 5 FEBRUARY 2021 – The COVAX ACT-Accelerator was established by the World Health Organization to contain the COVID-19 pandemic faster and more efficiently, by ensuring that successful diagnostics, vaccines and treatments are shared equitably across ALL countries. While Canada is the first and only G7 country to draw from the COVAX vaccine supply to date, we recognize that this framework was developed to support all countries to reach 20% vaccination coverage as quickly as possible. However, universal access to COVID-19 vaccines is the only solution to ending the pandemic for everyone. For many low-income countries, the COVAX supply is the only viable source of vaccinations for their citizens.
We call on Canada to continue our commitment to supporting low- and middle-income countries to recover from COVID-19. We must demonstrate global solidarity and leadership in supporting access to vaccines and treatment for low- and middle-income countries, in alignment with our values and commitments to the Sustainable Development Goals. This includes supporting low-income countries to become vaccine-ready as quickly as possible.
None of us are safe from COVID-19 until all of us are safe.
CARE has spokespeople available. For media inquiries, please contact:
email@example.com | 613-228-5641
About CARE Canada:
Founded in 1945 with the creation of the CARE Package®, CARE develops solutions alongside women and girls in developing countries to lift themselves, their families, and their communities out of poverty and out of crisis. CARE stands with women and girls around the world in economic empowerment. We bring women, girls, and their communities together to challenge inequality while facing issues like food insecurity, climate change, and emergency relief in times of crisis or disaster. CARE works in 100 countries around the world.
To learn more about CARE Canada, visit www.care.ca